| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $225K | — |
| R&D Expense | $5.2M | -49.8% |
| SG&A Expense | $11.7M | -38.6% |
| Operating Income | -$16.6M | +43.3% |
| Income Tax | $0 | — |
| Net Income | -$24.9M | +61.7% |
| EPS (Basic) | -$6.50 | -22.4% |
| EPS (Diluted) | -$6.50 | -22.4% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.2M | +230.4% |
| Accounts Receivable | $1.0M | — |
| Inventory | $0 | — |
| Current Assets | $15.7M | -40.3% |
| Total Assets | $28.7M | -30.3% |
| Current Liabilities | $3.8M | -82.2% |
| Total Liabilities | $7.4M | -71.3% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.6M | +39.0% |
| Capital Expenditures | $210K | -96.3% |
| Investing Cash Flow | $906K | -87.1% |
| Financing Cash Flow | $24.5M | +964.5% |
| Free Cash Flow | -$18.8M | +48.1% |
| Stockholders' Equity |
| $21.3M |
| +38.6% |